---
pmid: '23142079'
title: The deacetylase Sirt6 activates the acetyltransferase GCN5 and suppresses hepatic
  gluconeogenesis.
authors:
- Dominy JE Jr
- Lee Y
- Jedrychowski MP
- Chim H
- Jurczak MJ
- Camporez JP
- Ruan HB
- Feldman J
- Pierce K
- Mostoslavsky R
- Denu JM
- Clish CB
- Yang X
- Shulman GI
- Gygi SP
- Puigserver P
journal: Mol Cell
year: '2012'
full_text_available: false
pmcid: PMC3534905
doi: 10.1016/j.molcel.2012.09.030
---

# The deacetylase Sirt6 activates the acetyltransferase GCN5 and suppresses hepatic gluconeogenesis.
**Authors:** Dominy JE Jr, Lee Y, Jedrychowski MP, Chim H, Jurczak MJ, Camporez JP, Ruan HB, Feldman J, Pierce K, Mostoslavsky R, Denu JM, Clish CB, Yang X, Shulman GI, Gygi SP, Puigserver P
**Journal:** Mol Cell (2012)
**DOI:** [10.1016/j.molcel.2012.09.030](https://doi.org/10.1016/j.molcel.2012.09.030)
**PMC:** [PMC3534905](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534905/)

## Abstract

1. Mol Cell. 2012 Dec 28;48(6):900-13. doi: 10.1016/j.molcel.2012.09.030. Epub
2012  Nov 8.

The deacetylase Sirt6 activates the acetyltransferase GCN5 and suppresses 
hepatic gluconeogenesis.

Dominy JE Jr(1), Lee Y, Jedrychowski MP, Chim H, Jurczak MJ, Camporez JP, Ruan 
HB, Feldman J, Pierce K, Mostoslavsky R, Denu JM, Clish CB, Yang X, Shulman GI, 
Gygi SP, Puigserver P.

Author information:
(1)Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical 
School, Boston, MA 02115, USA.

Hepatic glucose production (HGP) maintains blood glucose levels during fasting 
but can also exacerbate diabetic hyperglycemia. HGP is dynamically controlled by 
a signaling/transcriptional network that regulates the expression/activity of 
gluconeogenic enzymes. A key mediator of gluconeogenic gene transcription is 
PGC-1α. PGC-1α's activation of gluconeogenic gene expression is dependent upon 
its acetylation state, which is controlled by the acetyltransferase GCN5 and the 
deacetylase Sirt1. Nevertheless, whether other chromatin modifiers-particularly 
other sirtuins-can modulate PGC-1α acetylation is currently unknown. Herein, we 
report that Sirt6 strongly controls PGC-1α acetylation. Surprisingly, Sirt6 
induces PGC-1α acetylation and suppresses HGP. Sirt6 depletion decreases PGC-1α 
acetylation and promotes HGP. These acetylation effects are GCN5 dependent: 
Sirt6 interacts with and modifies GCN5, enhancing GCN5's activity. Lepr(db/db) 
mice, an obese/diabetic animal model, exhibit reduced Sirt6 levels; ectopic 
re-expression suppresses gluconeogenic genes and normalizes glycemia. Activation 
of hepatic Sirt6 may therefore be therapeutically useful for treating 
insulin-resistant diabetes.

Copyright © 2012 Elsevier Inc. All rights reserved.

DOI: 10.1016/j.molcel.2012.09.030
PMCID: PMC3534905
PMID: 23142079 [Indexed for MEDLINE]
